Preferences of Persons With or at Risk for Hepatitis C for Long-Acting Treatments is a research paper published in Clinical Infectious Diseases (2021). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R01DA048063-04
Elimination of HCV and related liver disease among HIV-infected and -uninfected people who inject drugs
National Institutes of Health
Grant: 3P30AI094189-13S3
The Johns Hopkins Center for AIDS Research (JHU CFAR)
National Institutes of Health
Grant: 5K24DA034621-10
Midcareer Investigator Award in Patient-Oriented Research (Parent K24)
National Institutes of Health
Grant: 5R01DA040506-02
A randomised study of interferon-free treatment for recently acquired hepatitis C in people who inject drugs and people with HIV coinfection (the REACT Study)
National Institutes of Health
Grant: 5R01DA041736-03
Individual, Network and Spatial Drivers of HIV and HCV among PWID in India
National Institutes of Health
Grant: 5R24AI118397-10
The Long-Acting/Extended Release Antiretroviral Resource Program (LEAP)
National Institutes of Health
Grant: 5K24AI118591-03
Patient-Oriented Research and Mentorship in HIV and Non-Communicable Diseases
National Institutes of Health
Grant: 5U01DA036297-02
The AIDS Linked to the Intravenous Experience (ALIVE) Study
Fields of Study
Keywords
Sustainable Development Goals